These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
221 related articles for article (PubMed ID: 15628756)
1. [Chemotherapy for hepatocellular carcinoma]. Okusaka T; Ueno H; Ikeda M Gan To Kagaku Ryoho; 2004 Dec; 31(13):2122-8. PubMed ID: 15628756 [TBL] [Abstract][Full Text] [Related]
2. Biochemical modulation of doxorubicin by high-dose tamoxifen in the treatment of advanced hepatocellular carcinoma. Cheng AL; Yeh KH; Fine RL; Chuang SE; Yang CH; Wang LH; Chen DS Hepatogastroenterology; 1998; 45(24):1955-60. PubMed ID: 9951847 [TBL] [Abstract][Full Text] [Related]
3. [Postoperative adjuvant arterial infusion chemotherapy in patients with advanced hepatocellular carcinoma]. Nakashima K; Aramaki M; Kawano K; Yoshida T; Kim YI; Kitano S; Kobayashi M Gan To Kagaku Ryoho; 1995 Sep; 22(11):1483-5. PubMed ID: 7574738 [TBL] [Abstract][Full Text] [Related]
4. [Hepatic arterial infusion chemotherapy (HAIC)--hepatocellular carcinoma]. Osuga K; Murakami T; Nakata S; Tomoda K; Nagano H; Monden M; Nakamura H Gan To Kagaku Ryoho; 2004 Dec; 31(13):2114-7. PubMed ID: 15628754 [TBL] [Abstract][Full Text] [Related]
5. [The chemotherapy for hepatocellular carcinoma]. Nagano H; Sakon M; Monden M Gan To Kagaku Ryoho; 2003 Nov; 30(12):1895-900. PubMed ID: 14650956 [TBL] [Abstract][Full Text] [Related]
6. Postresectional adjuvant intraportal chemotherapy in patients with hepatocellular carcinoma: a case-control study. Chau GY; Lui WY; Tsay SH; Chao Y; King KL; Wu CW Ann Surg Oncol; 2006 Oct; 13(10):1329-37. PubMed ID: 16897271 [TBL] [Abstract][Full Text] [Related]
7. Chemotherapy using 5-fluorouracil, mitoxantrone, and cisplatin for patients with advanced hepatocellular carcinoma: an analysis of 63 cases. Yang TS; Chang HK; Chen JS; Lin YC; Liau CT; Chang WC J Gastroenterol; 2004; 39(4):362-9. PubMed ID: 15168248 [TBL] [Abstract][Full Text] [Related]
8. A phase II trial of continuous infusion of 5-fluorouracil, mitoxantrone, and cisplatin for metastatic hepatocellular carcinoma. Ikeda M; Okusaka T; Ueno H; Takezako Y; Morizane C Cancer; 2005 Feb; 103(4):756-62. PubMed ID: 15637692 [TBL] [Abstract][Full Text] [Related]
9. [The progress of hepatic arterial infusion chemotherapy for hepatocellular carcinoma]. Noda T; Nagano H; Wada H; Marubashi S; Miyamoto A; Takeda Y; Umeshita K; Dono K; Ohsuga K; Kim T; Tomoda K; Nakamura H; Monden M Gan To Kagaku Ryoho; 2006 Sep; 33(9):1221-5. PubMed ID: 16969014 [TBL] [Abstract][Full Text] [Related]
10. A randomized comparative study of high-dose and low-dose hepatic arterial infusion chemotherapy for intractable, advanced hepatocellular carcinoma. Woo HY; Bae SH; Park JY; Han KH; Chun HJ; Choi BG; Im HU; Choi JY; Yoon SK; Cheong JY; Cho SW; Jang BK; Hwang JS; Kim SG; Kim YS; Seo YS; Yim HJ; Um SH; Cancer Chemother Pharmacol; 2010 Jan; 65(2):373-82. PubMed ID: 19763572 [TBL] [Abstract][Full Text] [Related]
11. [Hepatocellular carcinoma (HCC): the long-term response to tamoxifen. A clinical case report and review of the literature]. Recchia F; Passalacqua G; Rodorigo C; Belli L; Morgante A; Rabitti G Minerva Med; 1989 Dec; 80(12):1363-6. PubMed ID: 2560153 [TBL] [Abstract][Full Text] [Related]
12. [Adjuvant chemotherapy after orthotopic liver transplantation for advanced hepatocellular carcinoma]. Zhang ZH; Ma LW; Song SB; Xiu DR; Wang JJ; Yang XX; Jia YM Zhonghua Zhong Liu Za Zhi; 2005 Jan; 27(1):45-7. PubMed ID: 15771799 [TBL] [Abstract][Full Text] [Related]
14. Predictive factors of outcome and tumor response to systemic chemotherapy in patients with metastatic hepatocellular carcinoma. Ikeda M; Okusaka T; Ueno H; Morizane C; Kojima Y; Iwasa S; Hagihara A Jpn J Clin Oncol; 2008 Oct; 38(10):675-82. PubMed ID: 18716041 [TBL] [Abstract][Full Text] [Related]
15. [Clinical study of low-dose cisplatin and 5-fluorouracil chemotherapy via implanted fusion port in 20 patients with advanced hepatocellular carcinoma with portal vein tumor thrombosis]. Naganuma A; Toyoda M; Hamada T; Hagiwara S; Yanagisawa M; Kosone T; Arai H; Abe T; Takagi H Gan To Kagaku Ryoho; 2007 May; 34(5):729-34. PubMed ID: 17496446 [TBL] [Abstract][Full Text] [Related]
16. Adjuvant hepatic chemotherapy after resection of solitary hepatocellular carcinoma associated with hepatitis B virus cirrhosis. Wen J; Shen WL; Yang SH Hepatobiliary Pancreat Dis Int; 2006 May; 5(2):224-7. PubMed ID: 16698580 [TBL] [Abstract][Full Text] [Related]
17. A novel intrahepatic arterial chemotherapy after radical resection for advanced hepatocellular carcinoma. Tanaka S; Shimada M; Shirabe K; Maehara S; Harimoto N; Tsujita E; Sugimachi K; Maehara Y Hepatogastroenterology; 2005; 52(63):862-5. PubMed ID: 15966221 [TBL] [Abstract][Full Text] [Related]
18. [Hepatic arterial infusion chemotherapy using totally implantable port system]. Takayasu Y; Yamamoto S; Ikeda J Gan To Kagaku Ryoho; 2000 Sep; 27(10):1516-20. PubMed ID: 11015995 [TBL] [Abstract][Full Text] [Related]
19. [Usefulness of continuous arterial infusion chemotherapy for post operative multiple recurrence and residual hepatocellular carcinoma]. Yanagi I; Koga A; Okuda K; Nishio T; Shibata J; Aso K; Matuo H; Nagashima J; So H; Nakayama T Gan To Kagaku Ryoho; 1996 Sep; 23(11):1419-21. PubMed ID: 8854768 [TBL] [Abstract][Full Text] [Related]
20. [Complete disappearance of metastatic lung tumors and mediastinal lymphnode in a case of hepatocellular carcinoma treated by low-dose 5-fluorouracil/cisplatin therapy]. Anami Y; Oguma S; Matsuda Y; Yamaki T; Sazawa Y; Komiya H; Izai J; Ota T Gan To Kagaku Ryoho; 2005 Nov; 32(12):1977-80. PubMed ID: 16282739 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]